| Symbol | BBLGW |
|---|---|
| Name | BONE BIOLOGICS CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Industrial Specialties |
| Address | 2 BURLINGTON WOODS DRIVE,STE. 100, BURLINGTON, Massachusetts, 01803, United States |
| Telephone | +1 781 - 552-4452 |
| Fax | — |
| — | |
| Website | https://www.bonebiologics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The companys portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. Additional info from NASDAQ: |
New Form 424B5 - Bone Biologics Corp <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001493152-26-010072 <b>Size:</b> 390 KB
Read moreNew Form 10-K - Bone Biologics Corp <b>Filed:</b> 2026-03-02 <b>AccNo:</b> 0001493152-26-008564 <b>Size:</b> 6 MB
Read more(85% Positive) BONE BIOLOGICS CORPORATION (BBLGW) Announces Enrollment Update for products Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations
Read moreBone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
Read moreNew Form SCHEDULE 13G/A - Bone Biologics Corp Filed: 2025-11-07 AccNo: 0001213900-25-107707 Size: 13 KB
Read moreNew Form S-8 - Bone Biologics Corp Filed: 2025-09-26 AccNo: 0001493152-25-015761 Size: 280 KB
Read moreNew Form 8-K - Bone Biologics Corp Filed: 2025-09-04 AccNo: 0001493152-25-012604 Size: 294 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read moreNew Form S-3/A - Bone Biologics Corp Filed: 2025-08-29 AccNo: 0001493152-25-012463 Size: 126 KB
Read moreNew Form SCHEDULE 13G - Bone Biologics Corp Filed: 2025-07-03 AccNo: 0001213900-25-061574 Size: 22 KB
Read more| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| NB1 | DEVICE | Approved | Degenerative Disc Disease | RECRUITING | NCT03810573 |